NCT06691451

Brief Summary

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Nov 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Nov 2024Mar 2027

Study Start

First participant enrolled

November 1, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

2.1 years

First QC Date

November 14, 2024

Last Update Submit

November 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison between the number of IBD patients with tendency to thrombosis in cases of activity-

    -investigate the presence of multiple mutations associated with IBD patients with or without vascular complications.

    Baseline

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study will be conducted at internal medicine department Assiut universty

You may qualify if:

  • Age (18yrs - 65yrs) both sex

You may not qualify if:

  • Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Yazici A, Senturk O, Aygun C, Celebi A, Caglayan C, Hulagu S. Thrombophilic Risk Factors in Patients With Inflammatory Bowel Disease. Gastroenterology Res. 2010 Jun;3(3):112-119. doi: 10.4021/gr2010.06.209w. Epub 2010 May 20.

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Central Study Contacts

Asmaa Mohammed Abdelaal, Master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr Asmaa Abdelaal

Study Record Dates

First Submitted

November 14, 2024

First Posted

November 15, 2024

Study Start

November 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

November 15, 2024

Record last verified: 2024-11